It's About To Get A Lot Harder To Buy Knock-off Ozempic

Nicolas Ortega for BIJessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life-changer. Her doctor prescribed the cheaper, generic version of the weight-loss drug after her insurer refused to cover Zepbound, the brand-name version made by Eli Lilly. DeBenedetto, now 43, tells me she's been prediabetic since her 20s, and after going through hormone injections with IVF, she's put on a worrying amount of weight she just can't take off.

Topics:  we    and    if you    nicolas ortega   bijessica debenedetto   novo   scott brunner   ceo   alliance   pharmacy compounding   october   outsourcing facilities association   the ofa   apc   melanie jay   nyu langone comprehensive program   obesity   john hertig   butler university's college   health sciences   b12   ok this   citi   federal food   drug   cosmetic act   when i   department   human services   donald trump   ozempic-skeptic robert f kennedy jr   trump   hertig   monjauro   american   brand-name glp-1s   emily stewart   debenedetto   eli   lilly   fda   fda-approved   nordisk   zepbound   in   pharmacy   business insider   ro    hertig   health   glp-1   hims    hers   january   ozempic   lot   patients   shortage   tirzepatide   compounded   compounders   people   semaglutide   access   medications   spokesperson   versions   list   stop   pharmacies   version   price   longer   company   money   lose   government   form   easily   switch   work   expensive   copy   manufacturers   patient   year   prescribed   reason   treat   doctor   december   cheaper   benefit   added   patient-specific   eventually   coverage   put   question   feels   treatment   resolved   ensure   cover   close   dose   successful   type   active   widely   alteration   option   pulled   unclear   personalized   world   set   party   decision   miracle   supposed   means   amount   guys   companies   concerns   period   warned   meet   clear   offer   stock   short   give   big   essential   time   real   market   demand   result   chocolates   circumstances   offered   long   specific   agency   lead   standardized   valid   thousands   copies   
BING NEWS:
  • It's about to get a lot harder to buy knock-off Ozempic
    Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access.
    01/21/2025 - 8:06 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News